Eleva Capital SAS

Fundamental concentrated ★Signal industrials specialist (81%) CIK 2054496
League rank
#884
in Fundamental concentrated · #7109 overall
Long book
$343.4M
Q1 2026
Positions
24
Top-10 weight
98%
concentration
Last quarter
+4.3%
SPY +14.8%
Turnover
of book per quarter

Strategy in plain words

auto-generated from filings

Eleva Capital SAS is a concentrated fundamental stock-picker, specialised in industrials (81% of the long book), running a $343.4M US long book across 24 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Current anchor positions: CRH PLC, AMER SPORTS INC, NVIDIA CORP, NETFLIX INC, ALPHABET INC-CL A.

We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q2 2025
+27.4%
Q3 2025
+3.9%
Q1 2026
+4.3%

Sector allocation

Industrials
83%
Technology
7%
Other
3%
Services media
2%
Healthcare
1%
Communications
1%
Consumer discretionary
1%
Financials
1%

Long book by quarter

$463.7M
Q2 2025
$378.8M
Q3 2025
$343.4M
Q1 2026

What does Eleva Capital own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
CRH CRH PLCIndustrials2.7M$279.1M81.3%Held
AS AMER SPORTS INCOther298.8K$9.8M2.9%Held
NVDA NVIDIA CORPTechnology52.0K$9.1M2.6%Held
NFLX NETFLIX INCServices media87.2K$8.4M2.4%Held
GOOGL ALPHABET INC-CL ATechnology28.0K$8.0M2.3%Held
ANET ARISTA NETWORKS INCTechnology47.0K$5.8M1.7%Held
AMZN AMAZON.COM INCConsumer discretionary16.2K$3.4M1.0%Held
TMUS T-MOBILE US INCCommunications14.3K$3.0M0.9%Held
HOOD ROBINHOOD MARKETS INC - AFinancials31.6K$2.2M0.6%Held
ONON ON HOLDING AG-CLASS AOther50.1K$1.7M0.5%Held
BSX BOSTON SCIENTIFIC CORPHealthcare26.7K$1.7M0.5%Held
SPOT SPOTIFY TECHNOLOGY SACommunications2.7K$1.3M0.4%Held
NAMS NEWAMSTERDAM PHARMA CO NVHealthcare25.7K$823K0.2%Held
CGON CG ONCOLOGY INCHealthcare8.3K$561K0.2%Held
ESPR ESPERION THERAPEUTICS INCHealthcare183.0K$502K0.1%Held
MLYS MINERALYS THERAPEUTICS INCHealthcare17.1K$463K0.1%Held
FENC FENNEC PHARMACEUTICALS INCHealthcare53.2K$327K0.1%Held
IRON DISC MEDICINE INCHealthcare5.1K$327K0.1%Held
VRDN VIRIDIAN THERAPEUTICS INCHealthcare7.1K$139K0.0%Held
FCX FREEPORT-MCMORAN INCMaterials2.3K$133K0.0%Held
ACHR ARCHER AVIATION INC-AIndustrials21.5K$111K0.0%Held
EWTX EDGEWISE THERAPEUTICS INCHealthcare17.5K$55K0.0%Held
AQST AQUESTIVE THERAPEUTICS INCHealthcare2.7K$11K0.0%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRApr 15, 202624$343.4M canonicalSEC ↗
Q3 202513F-HRNov 10, 202515$378.8M canonicalSEC ↗
Q2 202513F-HRAug 5, 202533$463.7M canonicalSEC ↗